Drug combination tests can destroy deadly skin cancer

Dramatic trial results indicate that a combination of two immunotherapy drugs can wipe out the most deadly form of skin cancer even when the disease is advanced.

Of 95 patients given the treatment, more than 60% were still alive after two years and of these a fifth (22%) had no detectable tumours remaining.

A total of 142 patients were randomly allocated either to receive two drugs, nivolumab and ipilimumab, or ipilimumab alone.